Furmonertinib Approved for First-Line Treatment
Today, Shanghai Allist Pharmaceuticals Co., Ltd. (stock code: 688578) announced that Furmonertinib had been approved by the National Medical Products Administration (NMPA) of China...
2022-06-29
1579
MORE >>